Tag: Tuberculosis

In adjusted analysis, 31 percent of people with concurrent diseases died

Compared with 2021, in 2022, TB incidence was higher among persons aged 4 years and younger and 15 to 24 years and lower in those aged 65 years and older

Eight-week treatment noninferior to standard regimen for composite of death, ongoing treatment, active disease at week 96

Task force recommends screening asymptomatic adults at increased risk for latent TB infection

Overall risk-benefit ratio seems to favor patients receiving linezolid at dose of 600 mg for 26 weeks

Efficacy of 92 percent found among at-risk COVID-19-unvaccinated individuals with type 1 diabetes

Treatment completion 90.4 percent for three months of rifapentine-isoniazid versus 50.5 percent for six months of isoniazid

Aziyo Biologics recalling 154 containers of the bone putty that includes human cells and is used in a range of orthopedic procedures

Rifapentine-based regimen with moxifloxacin noninferior to six-month control regimen of rifampin, isoniazid, pyrazinamide, ethambutol

Seroprevalence of anti-SARS-CoV-2 IgG lower for health care workers with history of BCG vaccination